Company name: Cantourage
Description: Developer and supplier of cannabinoid-containing medicines intended to pursue the well-being of patients with the help of medical cannabis. The company specializes in researching, developing and supplying dronabinol based medicines and ingredients, enabling patients, pharmacists and health insurance companies to reap the benefits from innovative and competitive medical cannabis therapies.
Year founded: 2019
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company raised an undisclosed amount of venture funding from Think.Health in 2019.
Number of active investors:
Profile last updated: 27-May-2020
Last known valuation:
Last known valuation date: